The International Directory of Biotechnology Companies 2009 is one of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published. It contains more than 3,000 biotechnology companies and 10,000 executives working in the industry around the world.

This powerful Directory is your connection to key decision-makers in the biotechnology industry in Europe, the Americas, the Asia & Pacific region, the Middle East and Africa.

No other international directory keeps you abreast of the thousands of personnel changes taking place due to company mergers, acquisitions, consolidations, and staff turnover. This Directory is a must-have for anyone who needs to find contacts in the biotechnology worldwide.

This Directory will enable you to:

• Pinpoint key executives
• Profile a market
• Build new business prospects
• Generate new customers
• Discover who your competitors are
• Make vital contacts
• Save the time, money and effort of doing your own research
• Identify alternative suppliers and manufacturers
• Source up-to-date company information
• Keep track of key staff movements
• Access a wealth of quality information on companies and key personnel worldwide.

Whether you are a product manager, in charge of marketing or simply interested to remain in touch with the latest developments in the biotechnology industry, this Directory will save you time and effort in finding the up-to-date information you need.

Company categories include in this Directory include:

• Biotechnology
• Genomics
• Biopharmaceuticals
• Gene Mapping
• Bioinformatics
• Gene Sequencing
• Biochips
• Pharmacogenomics & SNP’s
• Functional Genomics
• plus many more categories!

This Directory also covers senior personnel in key job function areas such as:

• Managing Directors/CEOs
• Strategy & Planning
• Directors
• Market Research
• Senior Management
• Regulatory & Legal Affairs
• Sales & Marketing
• Personnel
• Research & Development
• Business Development
• and much more!

Key Features of the Directory include:

• 3,000 biotechnology companies listed with description of company activities
• 10,000 senior biotechnology personnel listed with name & job title
• Full contact details including email and website addresses
• Global coverage of companies and key personnel
• Comprehensive Indexing

Coverage:

• Western & Eastern Europe incl. UK
• USA & Canada
• South & Central America
• The Middle East
• Africa
• East, South & North Asia incl. Japan
• Australasia and the Pacific

This Directory has been especially compiled to assist biotechnology professionals with market research, strategic planning, as well as contacting prospective clients or suppliers. It is also an indispensable guide to all of the world’s biotechnology companies and key biotechnology decision makers!

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1195/International-Directory-of-Biotechnology-Companies-2010.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

The leading business intelligence provider, has released its latest research, “Top 10 Biotechnology Companies – SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into the global biotechnology industry and analyzes the competitive positioning of the top 10 companies in the industry. This pharmaceutical and healthcare report estimates the market size of the global biotechnology industry and its future prospects. It benchmarks the leading companies in the biotechnology industry on selected parameters to analyze their competitive positioning in the market. The report analyzes the future landscape of the biotechnology industry by forecasting the revenues of leading companies to 2012. For each company the report analyzes the financial strength, product portfolio, pipeline strength and therapeutic focus of its R&D activities. It critically examines the strengths and weaknesses of individual companies and the opportunities and threats facing them.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The report analyses the competitive landscape of the biotechnology industry, R&D strategies and pipeline of the top 10 players, and strengths, weaknesses, opportunities and threats facing these companies. Its scope includes
- Market size of the global biotechnology industry and coverage of the changing competitive landscape from 2008 to 2012.
- Review of key industry drivers and restraints which are likely to impact the global biotechnology industry in the future.
- Analysis of the competitive positioning of the top 10 biotechnology companies globally.
- Analysis of pipeline products in the global biotech market by therapy area like cancer, infectious diseases, respiratory disorders, autoimmune disorders, and product classes.
- Financial analysis including annual revenues of top 10 companies from 2004 to 2008, with forecasts to 2012.
- SWOT analysis, DuPont analysis and financial benchmarking of the top 10 biotech companies.
- Analysis of the therapeutic focus, marketed products and product pipeline of top 10 biotech companies.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop a clear knowledge and understanding of the competitive landscape and how this will change in the coming years.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
- Make more informed business decisions from the insightful and in-depth analysis of the key strategies to be followed by competitors.
- Effectively plan your investment strategies by identifying companies with maximum investment potential.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.

Companies Mentioned

Amgen
Genentech (Roche)
Gilead Sciences
UCB Pharma
Genzyme
Biogen Idec
CSL Limited
Celgene
Cephalon
Actelion

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1208/Top-10-Biotechnology-Companies-SWOT-Analysis-Competitive-Benchmarking-Financial-Analysis-and-R-D-Pipeline.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market
http://www.visionshopsters.com/product/1123/Global-Biomaterial-Market-2009-2014-.html.

Biomaterials products had a market size of $25.5 billion in 2008, and the biomaterial device market size was $115.4 billion in the same year, and is expected to reach $252.7 billion in 2014. This massive revenue potential highlights the immense opportunity in the market. In the next five years, the biomaterials market is expected to grow at a CAGR of 15%.

Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market.

Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.

REPORT DESCRIPTION

This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:

• Biomaterials product market
Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others

• Biomaterials ingredient market
Metals, polymers, ceramics, composites

• Biomaterials application market
General, surgical appliances and supplies, surgical and medical instruments, dental products, electro-medical equipment, in-vitro diagnostic products, and other applications

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 50 company profiles for each of its sub-segments.

What makes our reports unique?

- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
- No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors:
Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1123/Global-Biomaterial-Market-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

The limited availability of petrol and its surging prices have brought about the development of alternative fuels such as biodiesel, bioethanol, and biogas. The major advantages of biodiesel are that it enhances engine life, and unlike petroleum, it does not pollute the environment.

The biodiesel market is slated for a huge growth in the next few years not only because of the growing environmental concerns, but also because of the surging prices for non-renewable sources of energy, especially petroleum. Governments across the globe are encouraging the use of biodiesel; and many countries have initiated blending of conventional diesel with a percentage of biodiesel.

This report analyzes the markets for the major feedstock currently used for biodiesel production, such as vegetable oils, waste oils, and animal fats; as well as potential feedstock such as algae, jatropha, and sunflower oil. The report includes an in-depth analysis of transesterification, the technology to convert oils to biodiesel, and a comparative analysis between conventional petrol diesel and biodiesel on parameters such as pricing, feedstock availability, and the potential to reduce greenhouse gas emissions.

The report extensively analyzes the automotive, aerospace, railways, and heating applications of biodiesel. Each of the major and micro biodiesel markets include detailed analysis of the factors influencing the market, trends and forecasts, competitive landscape, and in-depth geographic analysis of the biodiesel markets in the Americas, Europe, Asia and Rest of the World.

The report identifies factors that drive or inhibit market growth in order to support the market trends and forecasts made herein for each sub-segment. More than 38 company profiles are provided for a deeper insight into the competitive landscape. The market tables are categorized as per geographies and feedstocks.

The intended audience of this report includes :
• Biodiesel producers
• Feedstock suppliers
• Automotive manufacturers
• Aerospace companies and organizations
• Government authorities

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1479/Global-Biodiesel-Market.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars market. The global biosimilars market is expected to be worth US$19.4 billion by 2014, growing at a CAGR of 89.1% from 2009 to 2014. The biosimilars market is segmented into peptides, recombinant glycosylated proteins, recombinant non-glycosylated proteins, and others http://www.visionshopsters.com/product/1125/Biosimilars-2009-2014-.html.

The main factors driving the demand in the biosimilars market include increasing user acceptance, low costs and large application area, increasing governmental initiatives, and the emerging Indian and Chinese economies. The major challenges for the biosimilars market are the risks involved with the high investment and the possible failure of the drug during development stages. However, opportunities for biosimilarss market is immense, as biologics worth US$25 billion are going to be off-patent by 2016; and an anticipated approval pathway in U.S. will open up potentially largest market.

Asia’s early commercialization and high absorption rate of biosimilars products made it the dominant market in 2008 with 34.1% share of the global biosimilars market. The American market is expected to dominate in 2014 after the U.S. market opens up in 2010. Currently, the global biosimilars market is highly fragmented with major players such as Biocon, Dr. Reddy’s Lab, Intas, LG LifeSciences, Ranbaxy, Reliance LifeSciences, Sandoz, Teva, and Wockhardt. Favorable regulatory developments in the biosimilars sector are expected to increase the market shares and profit margins while reducing medical expenditure.

Scope of the Report

This report aims to identify and analyze biosimilars market on the basis of products, services, technology, and applications.

• Biosimilars product market
Peptides, recombinant glycosylated proteins, recombinant non-glycosylated proteins, and others

• Biosimilars service market
Contract research and manufacturing services, clinical trials services

• Biosimilars applications market
Oncology, infectious diseases, chronic and autoimmune diseases, and other diseases

• Biosimilars technology market
Recombinant DNA technology, monoclonal antibodies technologies, protein sequencing, bioassay, chromatography, nuclear magnetic resonance, and mass spectrometry

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 60 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 40 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW (Rest of the World).
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for the following sectors: Pharmaceuticals, medical devices, biotechnology, semiconductor and electronics, energy and power supplies, food and beverages, chemicals, advanced materials, industrial automation, and telecom and it. we also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1125/Biosimilars-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

The Global Biomarker Market report http://www.visionshopsters.com/product/1121/Biomarkers-Advanced-Technologies-and-Global-Market-2009-2014-.html analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.

The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery. The markets for biomarker tools and services are expected to grow at a CAGR of 18.5% and 22.2% respectively. The increasing use of biomarkers in clinical services is boosting the overall biomarker service market.

The high growth of biomarker market is boosted by the demand from the baby boomer generation in the U.S., and from Asia’s emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers. The use of proteomics in biomarker testing and identification has in turn boosted the services for the biomarkers. Market players are now focusing on new product and service development to enhance their commercial portfolios. Strategic collaborations among companies are also increasing biomarker applications in the field of diagnosis and drug discovery.

SCOPE AND FORMAT

The report analyzes the global biomarker market into the following segments:
• Tools Market (pregenomic biomarkers and technologies, postgenomic biomarkers and technologies, imaging biomarkers, and others)
• Services Market (pre- and post-clinical biomarker services, sample preparation, mirna analysis, and others)
• Application Market (diagnosis, and drug development and discovery)

The market data consists of aggregate sales figures of all biomarker submarkets. It analyzes the market aspects of new biomarker technologies and product launches; sourcing key market developments from the top companies that it profiles. The report also analyzes the documented claims and the biomarker technology patents approved over the last five years to provide an in-depth understanding of biomarker tools and services.

What makes our report unique?
• Provision of longest market segmentation in the industry.
• The report provides analysis of patents and more than 45 company profiles giving a competitive outlook.
• The report includes market data for segments such as tools, services and applications for the major geographies – U.S., Europe, Asian and ROW.
• The high level analysis provided by the report analyzes the market prospective for different major market segments along with the identification of opportunities.
• Provided competitive analysis stating the major segments focused by the global market players and the key developments – tools, services and technology.

Key questions answered
• Which are the high growth markets segments in terms of tools, services and applications?
• What are the market forecasts and estimates from the period 2009-14?
• What are the major drivers and opportunities in the market?
• What is the competitive outlook, what are the major tools and services, who are the major players in the market segments?

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1121/Biomarkers-Advanced-Technologies-and-Global-Market-2009-2014-.html

Contact Us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com